冠心病痰瘀证的多因素分析
|
摘要
目的研究冠心病痰瘀证与多种因素的相关性,探求冠心病痰瘀证的客观实质,为临床研究和决策提供线索和依据。
方法采集2006年2月—2009年2月在广州中医药大学第一附属医院心血管内科的住院病例,入选病例共163例,将冠心病患者分为痰瘀证组(87例)及非痰瘀证组(48例),并设立正常组作为对照(28例),完整收集病例资料,应用SPSS 17.0软件包建立数据库管理,对于计数资料,采用卡方检验,两两比较用卡方分割法;对于计量资料,两组资料比较采用T检验,三组资料比较采用单因素方差分析,若存在显著性差异,再进行多重检验进行两两比较。根据各观察指标的转换赋值表,进行Binary logistic回归分析,得出回归方程,并对回归模型进行似然比检验,评价模型的预测效果。
结果
1、痰瘀证为冠心病的主要证型,冠心病患者中痰瘀互结证占37.0%,瘀证占15.6%,痰证占11.9%,非痰瘀证占35.5%。
2、三组之间性别及年龄构成无显著性差异(P＞0.05);冠心病痰瘀证组的体重指数较其它两组高,痰瘀证组与正常组、痰瘀证组与非痰瘀证组之间两两比较,P值均小于0.05,有显著性差异。
3、在高血压病史、糖尿病病史、血脂异常史方面,冠心病痰瘀证组与正常组、冠心病非痰瘀证组与正常组比较,均有显著性差异(P＜0.05);冠心病痰瘀证组与非痰瘀证组在高血压病史、血脂异常史方面进行比较有显著性差异(P＜0.05),两组在糖尿病病史方面进行比较无显著性差异(P＞0.05)。
4、冠心病痰瘀证组与非痰瘀证组的症候计分比较具有显著性差异(P＜0.01),痰瘀证组的症候计分较高。
5、三组的白细胞总数、中性粒细胞百分比、空腹血糖及餐后2h血糖比较均无显著性差异(P＜0.05)。
6、痰瘀证组的TC、TG、LDL均有不同程度的升高,HDL有所降低;痰瘀证组与正常组、痰瘀证组与非痰瘀证组在TC、TG、LDL水平进行比较均有显著性差异(P＜0.05),而在HDL水平进行比较均无显著性差异(P＞0.05)。
7、冠心病痰瘀证组与正常组在CRP、TNF-α、IL-6、MMP-9、SCD40L、ICAM-1水平方面比较均有显著性差异(P＜0.05);与非痰瘀证组在CRP、TNF、IL-6、SCD40L、ICAM-1水平方面比较均有显著性差异(P＜0.05)。
8、痰瘀证组与非痰瘀证组冠脉的病变支数比较具有显著性差异(P＜0.05)。
9、对与冠心病痰瘀证相关的26项因素进行Binary Logistic回归分析,得出回归方程为:冠心病痰瘀证P=1/1+e~(-(-19.213+1.051×血脂异常史+2.226×症候计分+0.740×BMI+1.215×TC+1.092×TG+0.672×CRP+2.182×IL-6+2.851×SCD40L+1.918×ICAM-1+0.803×冠脉病变支数)回归过程中各部分的似然比检验的P值均小于0.05,回归方程的总体预测准确率达94.0%。
结论痰瘀证为冠心病的主要证型;在其相关的危险因素研究中,体重指数、高血压及血脂异常与冠心病痰瘀证的关系密切;冠心病痰瘀证组的症候计分较高,冠脉病变以多支病变为主,冠脉病变程度较重;血脂四项中TC、LDL水平的升高与冠心病痰瘀证的发病有密切的关系;炎症因子中CRP、TNF-α、IL-6、SCD40L、ICAM-1水平与冠心病痰瘀证的关系密切,此六项指标的升高对冠心病痰瘀证的影响较大;最终的Binary Logistic回归方程为:
冠心病痰瘀证P=1/1+e~(-(-19.213+1.051×血脂异常史+2.226×症候计分+0.740×BMI+1.215×TC+1.092×TG+0.672×CRP+2.182×IL-6+2.851×SCD40L+1.918×ICAM-1+0.803×冠脉病变支数),该方程的总体预测准确率达94.0%,预测效果较好。
Objective To study dependablity of the multiple factor and phlegm blood stasis syndrome(PBSS) of coronary heart disease(CHD),to explore the substance of the objective evidence of Phlegm and blood stasis of coronary heart disease, to provide clues and evidence for the research and decision for clinical
Method To Collect data of in-patient cases of cardiovascular endemic area in First Affiliated Hospital Guangzhou University of Traditional Chinese Medicine from January 2008 to March of 2009,A total of 163 cases is selected,which be divided into in group of PBSS(87 cases) and group of nonphlegm and blood stasis syndrome(NPBSS)(48 cases),And the normal group(28 cases),to collection completely information of cases,to establish of database management with software packages SPSS17.0,For count data,using chi-square test,Data for between each two groups,should be compared with chi-square partitioning;the measurement data,which between the two groups was compared using T test,and which for three sets of data wan used one-way ANOVA.if there was a significant difference,for Data for between each two groups,should be carried on the multiple examinations.According to each observation target evaluation table,all data was carried on Binary the logistic regression analysis.Then we can obtain the regression equation,the regression model should be carried on the likelihood ratio examination,and be evaluated for model forecast effect.
Result
1.The Phlegm and blood stasis is the main Syndrome of CHD.In patient of CHD, the phlegm stasis tiescard account for 37.0%mutually,the stasis accounts card for 15.6%,the phlegm card accounts for 11.9%,the non-phlegm stasis card accounts for 35.5%.
2.Three groups of sexes and age structure were non-significance difference (P＞0.05).coronary disease phlegm stasis group's body weight index was higher compared with other two groups.The data was compared between the group of PBSS with the normal group,and group of PBSS with the group of NPBSS,the two P value is smaller than 0.05.The results have the significance difference.
3.For hypertension medical history,diabetes medical history,blood fats unusual history,the result has the significance difference(P＜0.05) between group of PBSS of CHD with the normal group,and group of PBSS of CHD compares with the normal group.
4.For hypertension medical history,blood fats unusual history,the result has the significance difference(P＜0.05) between group of PBSS of CHD with the group of nPBSS of CHD.and has no significance difference for diabetes medical history.
5.The group of PBSS of CHD has the significance difference with group of NPBSS of CHD in aspect of symptom scoring comparison(P＜0.05).The group of PBSS scoring is higher.
6.The results of three group of comparison have not the significance difference(P＞0.05),in comparison in white blood cell total,neutral granular cell percentage,empty stomach blood sugar and meal,blood sugar.
7.The comparison between group of PBSS of CHD with the normal group in aspect of the Level of CRP,TNF,IL-6,MMP-9,SCD40L and ICAM-1 was different obviously (P＜0.05),which between group of PBSS of CHD with group of NPBSS of CHD had no significance difference in aspect of the Level of CRP,TNF,IL-6,SCD40L and ICAM-1
8.The result by comparison group of PBSS of CHD with t group of NPBSS of CHD in the count of crown arteries which have pathological change had the significance difference(P＜0.05).
9.The twenty-sixfactors related with phlegm stasis card of coronary disease were carried on the Binary Logistic regression analysis,then the regression equation is obtains,that is of the phlegm stasis of cardoronary disease P =1/1+e~(-(-19.213+1.051×history of blood fat abnormality +2.226×symptom sores +0.740×BMI +1.215×TC+1.092×TG+0.672×CRP+2.182×IL-6+2.851×SCD40L+1.918×ICAM-1+0.803×count of pathological crown arteries)) The P value for likelihood ratios to examine of all parts in the process of regression analysis was smaller than 0.05.The overall rate of accuracy to predicted by the regression equation reached 94.0%.
Conclusion Phlegm and blood stasis is the main Syndrome of CHD.In research to its hazard factors,the body weight index,hypertension and the blood fats are exceptionally closed with group of PBSS of CHD.Symptom scoring of group for PBSS is higher.Coronary artery pathological change of PBSS is by multi-pathological changes primarily,which coronary artery's pathological change degree is heavier.The morbility of PBSS of CHD has closed relationship with the rised level of TC、LDL in blood fats four items.PBSS of CHD has closed relationship with the level of CRP、TNF、IL-6、SCD40L、ICAM-1 in Inflammation factors
Horizontal elevation of that six indexes has the important influence with the PBSS of CHD.The final Binary Logistic regression equation for PBSS of CHDis: P=1/1+e~(-(-19.213+1.051×history of blood fat abnormality+2.226×symptom sores +0.740×BMI +1.215×TC+1.092×TG+0.672×CRP+2.182×IL-6+2.851×SCD40L+1.918×ICAM-1+0.803×count.of pathological crown arteries)) The overall rate of accuracy to predicted by the regression equation reached 94.0%.Which forecast effect is good.
方法采集2006年2月—2009年2月在广州中医药大学第一附属医院心血管内科的住院病例,入选病例共163例,将冠心病患者分为痰瘀证组(87例)及非痰瘀证组(48例),并设立正常组作为对照(28例),完整收集病例资料,应用SPSS 17.0软件包建立数据库管理,对于计数资料,采用卡方检验,两两比较用卡方分割法;对于计量资料,两组资料比较采用T检验,三组资料比较采用单因素方差分析,若存在显著性差异,再进行多重检验进行两两比较。根据各观察指标的转换赋值表,进行Binary logistic回归分析,得出回归方程,并对回归模型进行似然比检验,评价模型的预测效果。
结果
1、痰瘀证为冠心病的主要证型,冠心病患者中痰瘀互结证占37.0%,瘀证占15.6%,痰证占11.9%,非痰瘀证占35.5%。
2、三组之间性别及年龄构成无显著性差异(P＞0.05);冠心病痰瘀证组的体重指数较其它两组高,痰瘀证组与正常组、痰瘀证组与非痰瘀证组之间两两比较,P值均小于0.05,有显著性差异。
3、在高血压病史、糖尿病病史、血脂异常史方面,冠心病痰瘀证组与正常组、冠心病非痰瘀证组与正常组比较,均有显著性差异(P＜0.05);冠心病痰瘀证组与非痰瘀证组在高血压病史、血脂异常史方面进行比较有显著性差异(P＜0.05),两组在糖尿病病史方面进行比较无显著性差异(P＞0.05)。
4、冠心病痰瘀证组与非痰瘀证组的症候计分比较具有显著性差异(P＜0.01),痰瘀证组的症候计分较高。
5、三组的白细胞总数、中性粒细胞百分比、空腹血糖及餐后2h血糖比较均无显著性差异(P＜0.05)。
6、痰瘀证组的TC、TG、LDL均有不同程度的升高,HDL有所降低;痰瘀证组与正常组、痰瘀证组与非痰瘀证组在TC、TG、LDL水平进行比较均有显著性差异(P＜0.05),而在HDL水平进行比较均无显著性差异(P＞0.05)。
7、冠心病痰瘀证组与正常组在CRP、TNF-α、IL-6、MMP-9、SCD40L、ICAM-1水平方面比较均有显著性差异(P＜0.05);与非痰瘀证组在CRP、TNF、IL-6、SCD40L、ICAM-1水平方面比较均有显著性差异(P＜0.05)。
8、痰瘀证组与非痰瘀证组冠脉的病变支数比较具有显著性差异(P＜0.05)。
9、对与冠心病痰瘀证相关的26项因素进行Binary Logistic回归分析,得出回归方程为:冠心病痰瘀证P=1/1+e~(-(-19.213+1.051×血脂异常史+2.226×症候计分+0.740×BMI+1.215×TC+1.092×TG+0.672×CRP+2.182×IL-6+2.851×SCD40L+1.918×ICAM-1+0.803×冠脉病变支数)回归过程中各部分的似然比检验的P值均小于0.05,回归方程的总体预测准确率达94.0%。
结论痰瘀证为冠心病的主要证型;在其相关的危险因素研究中,体重指数、高血压及血脂异常与冠心病痰瘀证的关系密切;冠心病痰瘀证组的症候计分较高,冠脉病变以多支病变为主,冠脉病变程度较重;血脂四项中TC、LDL水平的升高与冠心病痰瘀证的发病有密切的关系;炎症因子中CRP、TNF-α、IL-6、SCD40L、ICAM-1水平与冠心病痰瘀证的关系密切,此六项指标的升高对冠心病痰瘀证的影响较大;最终的Binary Logistic回归方程为:
冠心病痰瘀证P=1/1+e~(-(-19.213+1.051×血脂异常史+2.226×症候计分+0.740×BMI+1.215×TC+1.092×TG+0.672×CRP+2.182×IL-6+2.851×SCD40L+1.918×ICAM-1+0.803×冠脉病变支数),该方程的总体预测准确率达94.0%,预测效果较好。
Objective To study dependablity of the multiple factor and phlegm blood stasis syndrome(PBSS) of coronary heart disease(CHD),to explore the substance of the objective evidence of Phlegm and blood stasis of coronary heart disease, to provide clues and evidence for the research and decision for clinical
Method To Collect data of in-patient cases of cardiovascular endemic area in First Affiliated Hospital Guangzhou University of Traditional Chinese Medicine from January 2008 to March of 2009,A total of 163 cases is selected,which be divided into in group of PBSS(87 cases) and group of nonphlegm and blood stasis syndrome(NPBSS)(48 cases),And the normal group(28 cases),to collection completely information of cases,to establish of database management with software packages SPSS17.0,For count data,using chi-square test,Data for between each two groups,should be compared with chi-square partitioning;the measurement data,which between the two groups was compared using T test,and which for three sets of data wan used one-way ANOVA.if there was a significant difference,for Data for between each two groups,should be carried on the multiple examinations.According to each observation target evaluation table,all data was carried on Binary the logistic regression analysis.Then we can obtain the regression equation,the regression model should be carried on the likelihood ratio examination,and be evaluated for model forecast effect.
Result
1.The Phlegm and blood stasis is the main Syndrome of CHD.In patient of CHD, the phlegm stasis tiescard account for 37.0%mutually,the stasis accounts card for 15.6%,the phlegm card accounts for 11.9%,the non-phlegm stasis card accounts for 35.5%.
2.Three groups of sexes and age structure were non-significance difference (P＞0.05).coronary disease phlegm stasis group's body weight index was higher compared with other two groups.The data was compared between the group of PBSS with the normal group,and group of PBSS with the group of NPBSS,the two P value is smaller than 0.05.The results have the significance difference.
3.For hypertension medical history,diabetes medical history,blood fats unusual history,the result has the significance difference(P＜0.05) between group of PBSS of CHD with the normal group,and group of PBSS of CHD compares with the normal group.
4.For hypertension medical history,blood fats unusual history,the result has the significance difference(P＜0.05) between group of PBSS of CHD with the group of nPBSS of CHD.and has no significance difference for diabetes medical history.
5.The group of PBSS of CHD has the significance difference with group of NPBSS of CHD in aspect of symptom scoring comparison(P＜0.05).The group of PBSS scoring is higher.
6.The results of three group of comparison have not the significance difference(P＞0.05),in comparison in white blood cell total,neutral granular cell percentage,empty stomach blood sugar and meal,blood sugar.
7.The comparison between group of PBSS of CHD with the normal group in aspect of the Level of CRP,TNF,IL-6,MMP-9,SCD40L and ICAM-1 was different obviously (P＜0.05),which between group of PBSS of CHD with group of NPBSS of CHD had no significance difference in aspect of the Level of CRP,TNF,IL-6,SCD40L and ICAM-1
8.The result by comparison group of PBSS of CHD with t group of NPBSS of CHD in the count of crown arteries which have pathological change had the significance difference(P＜0.05).
9.The twenty-sixfactors related with phlegm stasis card of coronary disease were carried on the Binary Logistic regression analysis,then the regression equation is obtains,that is of the phlegm stasis of cardoronary disease P =1/1+e~(-(-19.213+1.051×history of blood fat abnormality +2.226×symptom sores +0.740×BMI +1.215×TC+1.092×TG+0.672×CRP+2.182×IL-6+2.851×SCD40L+1.918×ICAM-1+0.803×count of pathological crown arteries)) The P value for likelihood ratios to examine of all parts in the process of regression analysis was smaller than 0.05.The overall rate of accuracy to predicted by the regression equation reached 94.0%.
Conclusion Phlegm and blood stasis is the main Syndrome of CHD.In research to its hazard factors,the body weight index,hypertension and the blood fats are exceptionally closed with group of PBSS of CHD.Symptom scoring of group for PBSS is higher.Coronary artery pathological change of PBSS is by multi-pathological changes primarily,which coronary artery's pathological change degree is heavier.The morbility of PBSS of CHD has closed relationship with the rised level of TC、LDL in blood fats four items.PBSS of CHD has closed relationship with the level of CRP、TNF、IL-6、SCD40L、ICAM-1 in Inflammation factors
Horizontal elevation of that six indexes has the important influence with the PBSS of CHD.The final Binary Logistic regression equation for PBSS of CHDis: P=1/1+e~(-(-19.213+1.051×history of blood fat abnormality+2.226×symptom sores +0.740×BMI +1.215×TC+1.092×TG+0.672×CRP+2.182×IL-6+2.851×SCD40L+1.918×ICAM-1+0.803×count.of pathological crown arteries)) The overall rate of accuracy to predicted by the regression equation reached 94.0%.Which forecast effect is good.
引文
[1]王薇.中国35-64岁人群血压水平与10年心血管病危险前瞻性研究.中华内科杂志,2004;43(10):730-734
[2]Mazza A,Tikhonof V,Schiavon L,etal.Triglycerides high-den--sity-lipoprotein-cholesterol dyslipidaemia,acoronary risk factor inelderly women:the Cardiovascular Study in the Elderly.InternMed J,2005;35:604-610.
[3]Howard BV,Best LG,Galloway JM,etal.Coronary heart disease risk equivalene in diabetes depends on concomitant risk factors.Diabetes Care,2006;29:391-397
[4]Mizuno K,Nakaya N,Ohashi Y,et al.Usefulness of pmvastin inprimary prevention of cardiovascar~ events in women:analysis of the 15 Management of Elevated Cholesterol in the Primary Prevention Group of Adult lapanese(MEGA study).Circulation,2008;4:494--502
[5]Pohiola--Sintonen S,Rissanen A,Liskola P,et al.Family history as a risk factor coronary heart disease in patients under 60 years of age Eur Heart T,1998;5:235-239
[6]Ross R.Atherosclerosis--an inflammatory disese.N EnglJ Med,1999;340(2):1 15--126
[7]何海英.冠心病患者C-反应蛋白的临床检测意义.中国综合临床,2006;22(2):116-117
[8]马腾,吴继雄等.血清C-反应蛋白、可溶性CD40配体、基质金属蛋白酶-2水平与冠心病的相关性.临床心血管病杂志,2007;23(3):171-173
[9]田彩霞,李艳等.外周血自细胞计数及C反应蛋白对冠心病的危险性评估.临床检验杂志,2006;24(6):438-439
[10]卢翠莲,纪红,严之.纤维蛋白原与冠心病的相关性探讨.临床误诊误治,2008:8.21(8):1-2
[11]王旋,程龙献,张红梅.白细胞介素-6与冠心病关系的探讨.临床心血管病杂志,2006;22(6):373-374
[12]韦叶生,唐任光.冠心病患者白细胞介素-6血清水平检测的临床意义.陕西医学杂志,2005;34(8):907-908
[13]李崇剑,徐耕.不同类型冠心病患者血清C-反应蛋白与白细胞介素-6比较.临床心血管病杂志,2003:19(10):585-586
[14]向萍霞.冠心病患者TNF-α水平及其基因多态性的研究,遗传.2004;26(6): 807-810
[15]卢成志.肿瘤坏死因子-α及氧化修饰低密度脂蛋白水平与冠状动脉病变程度相关性研究.中国综合临床,2004;20(4):292-293
[16]方崇峰,陈样新.基质金属蛋白酶-9与急性冠状动脉综合征的临床相关性研究.临床心血管病杂志,2005;21(3):150-152
[17]杨丽霞,杨玉霞.可溶性CD40配体和核转录因子PPARγ与冠状动脉病变的相关性研究.中国现代医学杂志,2006,16(18):2792-2800
[18]李江,彭道泉.冠心病患者血清SCD40L的检测及其临床意义.湖南大学学报,2003:28(6):611-612
[19]周朝霞,马爱群.血清可溶性CD40配体对急性冠状动脉综合征的诊断.西安交通大学学报(医学版),2006;27(1):33-35
[20]陈欣,张广天.血浆sTM和sICAM-1在急性冠脉综合征患者中的表达.天津医药,2006;34(3):10-172
[21]陈莹.冠心病患者外周血MCP-1、sICAM-1、CD11b水平的变化.陕西医学杂志,2005;34(8):931-634
[22]唐任光,韦叶生.冠心病患者E-选择素血清水平检测的临床意义.检验医学,2006;21(5):475-477
[23]杨立森,林媛豪.可溶性E-选择素对冠心病心绞痛的诊断意义.临床心血管病杂志,2003:19(5):272-274
[24]Barron HU,Harr SD,Radord MJ,et al.The association between white blood cell count and acute myocardial infaraction mortality inpatients >or--65 years age:findings fromthe cooperative cardiovascular project.J Am Coll Cardiol,2001;38(6):1654--1661.
[25]HiilisG S,DalseyW C。 TerreginoC A,et al.Altered CD181eukocyte integrin expression an d adhesive function in patients with acute corona syntrome.Heart,2001;85:702-704
[26]夏泠,李建军.冠心病患者血白细胞计数的临床价值.医学新知杂志,2002;12(2):86-88
[27]杨眷兰,沈荣春等.冠心病与外周血白细胞计数的关系.中国误诊学杂志,2006;6(9):1694-1695
[28]卫任龙,杨志健,贾恩志等.外周血白细胞计数与冠状动脉狭窄的相关性.中国介入心脏病学杂志,2005;13(4):241--243.
[29]孙雪岩等.血脂与冠状动脉病变的关系.中国循环杂志,2003;18(6):424-423
[30]关德明.冠心病患者甘油三酯一高密度脂蛋白轴监测的临床意义.哈尔滨医科大学学报,2005;39(6):515-517
[31]迟路湘,何国祥.胰岛素抵抗对冠脉血管病变的影响.第三军医大学学报,2004;26(5):89-91
[32]贾淑杰,米树华.胰岛素抵抗与冠心病的关系研究(附72例临床报告).中国实用内科杂志,2004;24(2):89-90
[33]王子宽.冠心病危险因素与中医证型相关性分析.陕西中医学院学,2008;31(6):15-16
[34]陈玉婷,胡娟娟.冠心病痰瘀辨证与相关生化指标关系探讨.浙江中西医结合杂志,2005;15(3):144-146
[35]洪永敦,黄衍寿等.冠心病中医证候与炎症因子关系的临床研究.广州中医药大学学报,2005;22(2):81-83
[36]杨徐杭,汶医宁,魏敏慧等.冠心病中医辨证与血清c反应蛋白的相关性研究[J].中医药学刊,2004;22(9):1649.11
[37]袁肇凯,黄献平,谭光波,等.冠心病血瘀证血管内皮细胞功能的检测分析[J].中国中西医结合杂志,2006;26(5):40
[38]王东生,袁肇凯.冠心病痰瘀证的微观辨证研究.中医杂志,2007;48(9):831-833
[39]何剑平,李小敏.冠心病中医辨证与血脂、脂蛋白关系的探讨.辽宁中医杂志,1998;11(25):505-506.
[40]吴焕林,阮新民,张敏州,等.冠心病冠状动脉搭桥术后患者的中医证候分析.广州中医药大学学报,2000;17(3):228-229.
[41]李锋,李秀云,王长海,等.51例冠状动脉病变程度与中医证型的关系分析,陕西中医,1996;17(9):393
[42]李小兵,方永奇.心脑血管病痰证宏观辨证的计量化研究.中国中医基础医学杂志,2000;6(5):44-46
[43]方永奇,黄可儿.痰证的血液循环特征初探.湖北中医杂志,1992;14(96):33-35
[44]王阶,陈可冀.冠心病血瘀证逐步回归分析.中西医结合杂志,1991;11(1):47-49
[45]沈绍功,王承德.中医心病诊断疗效标准与用药规范.北京:北京出版社,2001
[46]程爵棠.中国当代中医专家临床经验荟萃(一).北京:学苑出版社,1997:5
[47]赵益业,林晓忠.邓铁涛教授以心脾相关学说诊治冠心病经验介绍.新中医,2007;39(4):6
[48]曹洪欣,张华敏.痰瘀互结与冠心病机理辨识.中医药学刊,2001:19(6): 544-545.
[49]Stamler J.Stamler K.Intervention for the prevention and contml statesand internationl experience.Am J Med,1984;27:3
[50]董艳玲55例冠心病危险因素和冠状动脉病变特点分析.临床医学,2005;12.25(12):9-10
[51]Imanishi T,M walic,Ha ⅡO T,et al.EndOthelial prOgenitor ceil senescence is accelerated,n bOth expe mental hypertensive rats and paIients w essent hypertension[J].J Hypenen,2005;23(10):1831--1837
[52]Oliveras A,soler MJ,Martinz--Estrada OM,et al.Endot}lelial prOgenitOr cells arereducedin reffact。 ry hypertension[J].J Hum Hypertens,2008;22(3):183-190
[53]王红.冠心病危险因素对内皮祖细胞作用的研究进展.心血管病学进展,2008;29(6):898-899
[54]Deedwania PC.Mechanisms of endothelialdys function in the metabolicsyndrome.CurrDiabRe,2003;3:289-292
[55]李瑞杰,王亚娟,郑晓敏.糖尿病与冠心病循证医学的证据.中国医刊,2006;41(Ⅱ):652.
[56]Lamendola C.Hypertriglyeeridemia and Low high density LipoproteirLrisks for coronary artery disease.Cardiovase Nurs,2001;14(2):79-90.
[57]LaRosa JC,Cleeman J1.Cholesterol lowering as a Treatment for EstabHshed coronary disease.Circulation,1992;85(3):1229
[58]沈礼勇,肖珙.冠心病痰浊型与血清载脂蛋白、脂蛋白组分的关系.中国医药学报,1991;(1):36.
[59]林求诚,陈成东.冠心病中医辨证病理生理学基础初探.福建中医药,1989;20(3):12.
[60]何剑平,李小敏.冠心病中医辨证与血脂、脂蛋白关系的探讨.辽宁中医杂志,1998;11(25):505-506.
[61]黑卫可,李娟.冠心病痰瘀证与血液流变性及血脂关系的研究.河南中医,1993;3(13):112-114.
[62]周暇青,宋剑南,王宇辉,等,痰瘀同治对实验性高脂血证大鼠血管内皮的保护作用.中国中医基础医学杂志,1997;4(3):26-28.
[63]NakagomiA,Freedman SB Geczy CI3nterferon--gamma and ipopolysa ccharide po---tential temonocyte tissue factor induction byC-reactive protein relationship with age,SeX,and hormonere placement treatment[J].Circulation, 2000:101:1785-1791
[64]王强程胜冠心病心绞痛中医证型与IL-18、hs-C RP的相关性探讨.广西中医药,2008;8.31(4):14-15
[65]王乐平,付海英.痰瘀与冠心病的关系探析及思考.中医药学刊,2006;24(1):41-42
[66]刘艳,叶武,冠心病痰瘀辨证与相关炎症标志物关系初探.中华中医药杂志(原中国医药学报),2008;12.23.(12):1121-1122
[67]华军益,刘艳.冠心病痰瘀辨证与血清炎症因子关系的临床研究.中西医结合,2008;37(3):112-113
[68]李静,张继东,刘同涛。冠心病中医证型与冠脉病变的相关性.山东中医药大学学报,2006;3.30(2):124-125
[69]王东生,袁肇凯,魏经汉等.冠心病痰瘀辨证与冠状动脉造影的相关性研究.中医杂志,2003;12.4(12):937-938
[2]Mazza A,Tikhonof V,Schiavon L,etal.Triglycerides high-den--sity-lipoprotein-cholesterol dyslipidaemia,acoronary risk factor inelderly women:the Cardiovascular Study in the Elderly.InternMed J,2005;35:604-610.
[3]Howard BV,Best LG,Galloway JM,etal.Coronary heart disease risk equivalene in diabetes depends on concomitant risk factors.Diabetes Care,2006;29:391-397
[4]Mizuno K,Nakaya N,Ohashi Y,et al.Usefulness of pmvastin inprimary prevention of cardiovascar~ events in women:analysis of the 15 Management of Elevated Cholesterol in the Primary Prevention Group of Adult lapanese(MEGA study).Circulation,2008;4:494--502
[5]Pohiola--Sintonen S,Rissanen A,Liskola P,et al.Family history as a risk factor coronary heart disease in patients under 60 years of age Eur Heart T,1998;5:235-239
[6]Ross R.Atherosclerosis--an inflammatory disese.N EnglJ Med,1999;340(2):1 15--126
[7]何海英.冠心病患者C-反应蛋白的临床检测意义.中国综合临床,2006;22(2):116-117
[8]马腾,吴继雄等.血清C-反应蛋白、可溶性CD40配体、基质金属蛋白酶-2水平与冠心病的相关性.临床心血管病杂志,2007;23(3):171-173
[9]田彩霞,李艳等.外周血自细胞计数及C反应蛋白对冠心病的危险性评估.临床检验杂志,2006;24(6):438-439
[10]卢翠莲,纪红,严之.纤维蛋白原与冠心病的相关性探讨.临床误诊误治,2008:8.21(8):1-2
[11]王旋,程龙献,张红梅.白细胞介素-6与冠心病关系的探讨.临床心血管病杂志,2006;22(6):373-374
[12]韦叶生,唐任光.冠心病患者白细胞介素-6血清水平检测的临床意义.陕西医学杂志,2005;34(8):907-908
[13]李崇剑,徐耕.不同类型冠心病患者血清C-反应蛋白与白细胞介素-6比较.临床心血管病杂志,2003:19(10):585-586
[14]向萍霞.冠心病患者TNF-α水平及其基因多态性的研究,遗传.2004;26(6): 807-810
[15]卢成志.肿瘤坏死因子-α及氧化修饰低密度脂蛋白水平与冠状动脉病变程度相关性研究.中国综合临床,2004;20(4):292-293
[16]方崇峰,陈样新.基质金属蛋白酶-9与急性冠状动脉综合征的临床相关性研究.临床心血管病杂志,2005;21(3):150-152
[17]杨丽霞,杨玉霞.可溶性CD40配体和核转录因子PPARγ与冠状动脉病变的相关性研究.中国现代医学杂志,2006,16(18):2792-2800
[18]李江,彭道泉.冠心病患者血清SCD40L的检测及其临床意义.湖南大学学报,2003:28(6):611-612
[19]周朝霞,马爱群.血清可溶性CD40配体对急性冠状动脉综合征的诊断.西安交通大学学报(医学版),2006;27(1):33-35
[20]陈欣,张广天.血浆sTM和sICAM-1在急性冠脉综合征患者中的表达.天津医药,2006;34(3):10-172
[21]陈莹.冠心病患者外周血MCP-1、sICAM-1、CD11b水平的变化.陕西医学杂志,2005;34(8):931-634
[22]唐任光,韦叶生.冠心病患者E-选择素血清水平检测的临床意义.检验医学,2006;21(5):475-477
[23]杨立森,林媛豪.可溶性E-选择素对冠心病心绞痛的诊断意义.临床心血管病杂志,2003:19(5):272-274
[24]Barron HU,Harr SD,Radord MJ,et al.The association between white blood cell count and acute myocardial infaraction mortality inpatients >or--65 years age:findings fromthe cooperative cardiovascular project.J Am Coll Cardiol,2001;38(6):1654--1661.
[25]HiilisG S,DalseyW C。 TerreginoC A,et al.Altered CD181eukocyte integrin expression an d adhesive function in patients with acute corona syntrome.Heart,2001;85:702-704
[26]夏泠,李建军.冠心病患者血白细胞计数的临床价值.医学新知杂志,2002;12(2):86-88
[27]杨眷兰,沈荣春等.冠心病与外周血白细胞计数的关系.中国误诊学杂志,2006;6(9):1694-1695
[28]卫任龙,杨志健,贾恩志等.外周血白细胞计数与冠状动脉狭窄的相关性.中国介入心脏病学杂志,2005;13(4):241--243.
[29]孙雪岩等.血脂与冠状动脉病变的关系.中国循环杂志,2003;18(6):424-423
[30]关德明.冠心病患者甘油三酯一高密度脂蛋白轴监测的临床意义.哈尔滨医科大学学报,2005;39(6):515-517
[31]迟路湘,何国祥.胰岛素抵抗对冠脉血管病变的影响.第三军医大学学报,2004;26(5):89-91
[32]贾淑杰,米树华.胰岛素抵抗与冠心病的关系研究(附72例临床报告).中国实用内科杂志,2004;24(2):89-90
[33]王子宽.冠心病危险因素与中医证型相关性分析.陕西中医学院学,2008;31(6):15-16
[34]陈玉婷,胡娟娟.冠心病痰瘀辨证与相关生化指标关系探讨.浙江中西医结合杂志,2005;15(3):144-146
[35]洪永敦,黄衍寿等.冠心病中医证候与炎症因子关系的临床研究.广州中医药大学学报,2005;22(2):81-83
[36]杨徐杭,汶医宁,魏敏慧等.冠心病中医辨证与血清c反应蛋白的相关性研究[J].中医药学刊,2004;22(9):1649.11
[37]袁肇凯,黄献平,谭光波,等.冠心病血瘀证血管内皮细胞功能的检测分析[J].中国中西医结合杂志,2006;26(5):40
[38]王东生,袁肇凯.冠心病痰瘀证的微观辨证研究.中医杂志,2007;48(9):831-833
[39]何剑平,李小敏.冠心病中医辨证与血脂、脂蛋白关系的探讨.辽宁中医杂志,1998;11(25):505-506.
[40]吴焕林,阮新民,张敏州,等.冠心病冠状动脉搭桥术后患者的中医证候分析.广州中医药大学学报,2000;17(3):228-229.
[41]李锋,李秀云,王长海,等.51例冠状动脉病变程度与中医证型的关系分析,陕西中医,1996;17(9):393
[42]李小兵,方永奇.心脑血管病痰证宏观辨证的计量化研究.中国中医基础医学杂志,2000;6(5):44-46
[43]方永奇,黄可儿.痰证的血液循环特征初探.湖北中医杂志,1992;14(96):33-35
[44]王阶,陈可冀.冠心病血瘀证逐步回归分析.中西医结合杂志,1991;11(1):47-49
[45]沈绍功,王承德.中医心病诊断疗效标准与用药规范.北京:北京出版社,2001
[46]程爵棠.中国当代中医专家临床经验荟萃(一).北京:学苑出版社,1997:5
[47]赵益业,林晓忠.邓铁涛教授以心脾相关学说诊治冠心病经验介绍.新中医,2007;39(4):6
[48]曹洪欣,张华敏.痰瘀互结与冠心病机理辨识.中医药学刊,2001:19(6): 544-545.
[49]Stamler J.Stamler K.Intervention for the prevention and contml statesand internationl experience.Am J Med,1984;27:3
[50]董艳玲55例冠心病危险因素和冠状动脉病变特点分析.临床医学,2005;12.25(12):9-10
[51]Imanishi T,M walic,Ha ⅡO T,et al.EndOthelial prOgenitor ceil senescence is accelerated,n bOth expe mental hypertensive rats and paIients w essent hypertension[J].J Hypenen,2005;23(10):1831--1837
[52]Oliveras A,soler MJ,Martinz--Estrada OM,et al.Endot}lelial prOgenitOr cells arereducedin reffact。 ry hypertension[J].J Hum Hypertens,2008;22(3):183-190
[53]王红.冠心病危险因素对内皮祖细胞作用的研究进展.心血管病学进展,2008;29(6):898-899
[54]Deedwania PC.Mechanisms of endothelialdys function in the metabolicsyndrome.CurrDiabRe,2003;3:289-292
[55]李瑞杰,王亚娟,郑晓敏.糖尿病与冠心病循证医学的证据.中国医刊,2006;41(Ⅱ):652.
[56]Lamendola C.Hypertriglyeeridemia and Low high density LipoproteirLrisks for coronary artery disease.Cardiovase Nurs,2001;14(2):79-90.
[57]LaRosa JC,Cleeman J1.Cholesterol lowering as a Treatment for EstabHshed coronary disease.Circulation,1992;85(3):1229
[58]沈礼勇,肖珙.冠心病痰浊型与血清载脂蛋白、脂蛋白组分的关系.中国医药学报,1991;(1):36.
[59]林求诚,陈成东.冠心病中医辨证病理生理学基础初探.福建中医药,1989;20(3):12.
[60]何剑平,李小敏.冠心病中医辨证与血脂、脂蛋白关系的探讨.辽宁中医杂志,1998;11(25):505-506.
[61]黑卫可,李娟.冠心病痰瘀证与血液流变性及血脂关系的研究.河南中医,1993;3(13):112-114.
[62]周暇青,宋剑南,王宇辉,等,痰瘀同治对实验性高脂血证大鼠血管内皮的保护作用.中国中医基础医学杂志,1997;4(3):26-28.
[63]NakagomiA,Freedman SB Geczy CI3nterferon--gamma and ipopolysa ccharide po---tential temonocyte tissue factor induction byC-reactive protein relationship with age,SeX,and hormonere placement treatment[J].Circulation, 2000:101:1785-1791
[64]王强程胜冠心病心绞痛中医证型与IL-18、hs-C RP的相关性探讨.广西中医药,2008;8.31(4):14-15
[65]王乐平,付海英.痰瘀与冠心病的关系探析及思考.中医药学刊,2006;24(1):41-42
[66]刘艳,叶武,冠心病痰瘀辨证与相关炎症标志物关系初探.中华中医药杂志(原中国医药学报),2008;12.23.(12):1121-1122
[67]华军益,刘艳.冠心病痰瘀辨证与血清炎症因子关系的临床研究.中西医结合,2008;37(3):112-113
[68]李静,张继东,刘同涛。冠心病中医证型与冠脉病变的相关性.山东中医药大学学报,2006;3.30(2):124-125
[69]王东生,袁肇凯,魏经汉等.冠心病痰瘀辨证与冠状动脉造影的相关性研究.中医杂志,2003;12.4(12):937-938